ENTITY

Apellis Pharmaceuticals (APLS US)

35
Analysis
Health CareUnited States
Apellis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. Apellis Pharmaceuticals serves clients worldwide.
more
Refresh
Company Event30 Oct 2024 20:00 • Upcoming
Add To Calendar
Company Event08 Aug 2024 20:00 • Latest
Company Event01 Aug 2024 20:30
Company Event07 May 2024 20:30
Company Event27 Feb 2024 21:30
x